Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 325

1.

The Opportunity Cost of Capital: Development of New Pharmaceuticals.

Chit A, Chit A, Papadimitropoulos M, Krahn M, Parker J, Grootendorst P.

Inquiry. 2015 May 1;52. pii: 0046958015584641. Print 2015.

PMID:
25933615
2.

Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014.

Ahmed S, Bathe O, Berry S, Buie D, Davies J, Doll C, Dowden S, Gill S, Gordon V, Hebbard P, Jones E, Kennecke H, Koski S, Krahn M, Le D, Lim H, Lund C, Luo Y, Mcffadden A, Mcghie J, Mulder K, Park J, Rashidi F, Sami A, Tan KT, Wong R.

Curr Oncol. 2015 Apr;22(2):e113-23. doi: 10.3747/co.22.2362.

3.

Economic evaluation of hormonal therapies for postmenopausal women with estrogen receptor-positive early breast cancer in Canada.

Djalalov S, Beca J, Amir E, Krahn M, Trudeau ME, Hoch JS.

Curr Oncol. 2015 Apr;22(2):84-96. doi: 10.3747/co.22.2120.

4.

A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.

Alibhai SM, Santa Mina D, Ritvo P, Sabiston C, Krahn M, Tomlinson G, Matthew A, Segal R, Warde P, Durbano S, O'Neill M, Culos-Reed N.

BMC Cancer. 2015 Apr 25;15(1):312. doi: 10.1186/s12885-015-1316-8.

5.

Towards an objective measure of functional disability in dysferlinopathy.

Woudt L, Di Capua GA, Krahn M, Castiglioni C, Hughes R, Campero M, Trangulao A, González-Hormazábal P, Godoy-Herrera R, Lévy N, Urtizberea JA, Jara L, Bevilacqua JA.

Muscle Nerve. 2015 Apr 21. doi: 10.1002/mus.24685. [Epub ahead of print]

PMID:
25900324
6.

The Economic Impact of Clostridium difficile Infection: A Systematic Review.

Nanwa N, Kendzerska T, Krahn M, Kwong JC, Daneman N, Witteman W, Mittmann N, Cadarette SM, Rosella L, Sander B.

Am J Gastroenterol. 2015 Apr;110(4):511-519. doi: 10.1038/ajg.2015.48. Epub 2015 Apr 7. Review.

PMID:
25848925
7.

Localization and Function of Pals1 Associated Tight Junction Protein in Drosophila is Regulated by Two Distinct Apical Complexes.

Sen A, Sun R, Krahn MP.

J Biol Chem. 2015 Apr 6. pii: jbc.M114.629014. [Epub ahead of print]

8.

Long-term impact of androgen-deprivation therapy on physical function and quality of life.

Alibhai SM, Breunis H, Timilshina N, Naglie G, Tannock I, Krahn M, Warde P, Fleshner NE, Canning SD, Tomlinson G.

Cancer. 2015 Mar 24. doi: 10.1002/cncr.29355. [Epub ahead of print]

PMID:
25809861
9.

Improving molecular diagnosis of distal myopathies by targeted next-generation sequencing.

Sevy A, Cerino M, Gorokhova S, Dionnet E, Mathieu Y, Verschueren A, Franques J, Maues de Paula A, Figarella-Branger D, Lagarde A, Desvignes JP, Béroud C, Attarian S, Levy N, Bartoli M, Krahn M, Campana-Salort E, Pouget J.

J Neurol Neurosurg Psychiatry. 2015 Mar 17. pii: jnnp-2014-309663. doi: 10.1136/jnnp-2014-309663. [Epub ahead of print] No abstract available.

PMID:
25783436
10.

Bazooka/PAR3 is dispensable for polarity in Drosophila follicular epithelial cells.

Shahab J, Tiwari MD, Honemann-Capito M, Krahn MP, Wodarz A.

Biol Open. 2015 Mar 13;4(4):528-41. doi: 10.1242/bio.201410934.

11.

Care in the Home for the Management of Chronic Heart Failure: Systematic Review and Cost-Effectiveness Analysis.

Fergenbaum J, Bermingham S, Krahn M, Alter D, Demers C.

J Cardiovasc Nurs. 2015 Feb 5. [Epub ahead of print]

PMID:
25658188
12.

Identification of Variants in the 4q35 Gene FAT1 in Patients with a Facioscapulohumeral Dystrophy-Like Phenotype.

Puppo F, Dionnet E, Gaillard MC, Gaildrat P, Castro C, Vovan C, Bertaux K, Bernard R, Attarian S, Goto K, Nishino I, Hayashi Y, Magdinier F, Krahn M, Helmbacher F, Bartoli M, Lévy N.

Hum Mutat. 2015 Apr;36(4):443-53. doi: 10.1002/humu.22760. Epub 2015 Mar 19.

PMID:
25615407
13.

Clinical heterogeneity and a high proportion of novel mutations in a Chinese cohort of patients with dysferlinopathy.

Xi J, Blandin G, Lu J, Luo S, Zhu W, Béroud C, Pécheux C, Labelle V, Lévy N, Urtizberea JA, Zhao C, Krahn M.

Neurol India. 2014 Nov-Dec;62(6):635-9. doi: 10.4103/0028-3886.149386.

14.

Cost-effectiveness of screening for hepatitis C in Canada.

Wong WW, Tu HA, Feld JJ, Wong T, Krahn M.

CMAJ. 2015 Feb 17;187(3):E110-21. doi: 10.1503/cmaj.140711. Epub 2015 Jan 12.

15.

Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial.

Fowler RA, Mittmann N, Geerts WH, Heels-Ansdell D, Gould MK, Guyatt G, Krahn M, Finfer S, Pinto R, Chan B, Ormanidhi O, Arabi Y, Qushmaq I, Rocha MG, Dodek P, McIntyre L, Hall R, Ferguson ND, Mehta S, Marshall JC, Doig CJ, Muscedere J, Jacka MJ, Klinger JR, Vlahakis N, Orford N, Seppelt I, Skrobik YK, Sud S, Cade JF, Cooper J, Cook D.

Trials. 2014 Dec 20;15(1):502. [Epub ahead of print]

16.

Structure and characteristics of community-based multidisciplinary wound care teams in Ontario: An environmental scan.

Abrahamyan L, Wong J, Pham B, Trubiani G, Carcone S, Mitsakakis N, Rosen L, Rac VE, Krahn M.

Wound Repair Regen. 2015 Jan;23(1):22-9. doi: 10.1111/wrr.12241. Epub 2015 Feb 13.

PMID:
25421743
17.

Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.

Fowler RA, Mittmann N, Geerts W, Heels-Ansdell D, Gould MK, Guyatt G, Krahn M, Finfer S, Pinto R, Chan B, Ormanidhi O, Arabi Y, Qushmaq I, Rocha MG, Dodek P, McIntyre L, Hall R, Ferguson ND, Mehta S, Marshall JC, Doig CJ, Muscedere J, Jacka MJ, Klinger JR, Vlahakis N, Orford N, Seppelt I, Skrobik YK, Sud S, Cade JF, Cooper J, Cook D; Canadian Critical Care Trials Group; Australia and New Zealand Intensive Care Society Clinical Trials Group.

JAMA. 2014 Nov 26;312(20):2135-45. doi: 10.1001/jama.2014.15101.

PMID:
25362228
18.

Prostate cancer screening: going beyond the clinical evidence.

Krahn M.

CMAJ. 2014 Nov 4;186(16):1201-2. doi: 10.1503/cmaj.141252. Epub 2014 Oct 27. No abstract available.

PMID:
25349002
19.

Identification of splicing defects caused by mutations in the dysferlin gene.

Kergourlay V, Raï G, Blandin G, Salgado D, Béroud C, Lévy N, Krahn M, Bartoli M.

Hum Mutat. 2014 Dec;35(12):1532-41. doi: 10.1002/humu.22710.

PMID:
25312915
20.

Identifying future research priorities using value of information analyses: left atrial appendage occlusion devices in atrial fibrillation.

Micieli A, Bennell MC, Pham B, Krahn M, Singh SM, Wijeysundera HC.

J Am Heart Assoc. 2014 Sep 16;3(5):e001031. doi: 10.1161/JAHA.114.001031.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk